{"id":"NCT02514577","sponsor":"Bausch Health Americas, Inc.","briefTitle":"Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis","officialTitle":"A Phase 3, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP-122 in the Treatment of Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11-07","primaryCompletion":"2017-05-01","completion":"2017-05-01","firstPosted":"2015-08-03","resultsPosted":"2020-01-27","lastUpdate":"2020-01-27"},"enrollment":217,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"IDP-122 Lotion","otherNames":["HP 0.01%"]},{"type":"DRUG","name":"IDP-122 Vehicle Lotion","otherNames":[]}],"arms":[{"label":"IDP-122 Lotion","type":"EXPERIMENTAL"},{"label":"IDP-122 Vehicle Lotion","type":"ACTIVE_COMPARATOR"}],"summary":"This study is to evaluate the safety and efficacy of a topical lotion when applied once daily to adult participants with moderate to severe plaque psoriasis (defined as an Investigator's Global Assessment \\[IGA\\] score of 3 or 4).","primaryOutcome":{"measure":"Percentage of Participants With Treatment Success at Week 8","timeFrame":"Week 8","effectByArm":[{"arm":"IDP-122 Lotion","deltaMin":36.5,"sd":null},{"arm":"IDP-122 Vehicle Lotion","deltaMin":8.13,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":15,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":142},"commonTop":[]}}